Sensitivity of Hyomental Distance Ratio as a Single Predictor of Difficult Intubation in Obstetrics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

188 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a study to detect the sensitivity of thyromental distance ratio as a single predictor for difficult intubation in patients undergoing cesarean section under general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The authors intend to use the HMDR for detection of difficult intubation in parturient undergoing cesarean section that is either elective or emergency.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caesarean Section

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Difficult intubation Hyomental distance Obstetric Mallampati classification Thyromental distance Sternomental distance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients presenting for cesarean section under general anesthesia

Exclusion Criteria

* None

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Waleed Riad, MD, AB, SB

Role: PRINCIPAL_INVESTIGATOR

King Khaled Eye Specialist Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al Corniche Hospital

Abu Dhabi, , United Arab Emirates

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACH 0901

Identifier Type: -

Identifier Source: org_study_id